ResearcherFirst Affiliated Hospital of Zhengzhou UniversityNo recent work listed
Lin Zhou
Matched on ORCID iD 0000-0002-2245-4412; OpenAlex author ID A5101533713.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 2
- MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway. First author DOI 10.1002/jcp.29468↗
- Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy. First author DOI 10.1016/j.canlet.2011.03.011↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Lianfeng Zhang · 1 shared paper, 2020
- Yaozong Yuan · 1 shared paper, 2011
- Weiyan Yao · 1 shared paper, 2011
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.